When administered, these medications work through several mechanisms: Slowing gastric emptying - Food remains in the stomach longer, which can contribute to feelings of fullness Reducing appetite signaling - The medications act on brain regions involved in hunger and satiety Improving insulin secretion - In response to food intake, insulin release becomes more efficient, which is why these medications were originally developed for diabetes Decreasing glucagon secretion - This hormone raises blood sugar, so reducing it helps with glucose control The two primary GLP-1 receptor agonists used for weight loss are: Semaglutide - FDA-approved for weight management under the brand name Wegovy (also sold as Ozempic for diabetes and Rybelsus as an oral diabetes medication)
Meanwhile, compounders, telehealth companies, and med spas have collaborated to meet high demand for weight loss injections and, recently, oral treatments, often straining and skirting regulations that protect the health of the public
Molecular basis of ligand recognition and activation of human V2 vasopressin receptor
Ramalingam SS Inhibition of insulin-like growth factor receptor: end of a targeted therapy
If your turkey fryer does not have a thermostat, use a kitchen thermometer that attaches to the side of the pot
However, since Zepbound is the only GLP-1 FDA-approved for OSA, you may have strong grounds for a formulary exception
